Status:

COMPLETED

HOMA-IR as a Screening Test in NAFLD

Lead Sponsor:

Fayoum University

Conditions:

NAFLD

Eligibility:

All Genders

40+ years

Brief Summary

The aim of this study is to evaluate the role of HOMA-IR in diagnosis of NAFLD in patients with type 2 DM.

Detailed Description

this study is a retrospective cohort study included 100 patients with type 2 DM from the outpatient clinic of internal medicine department at Fayoum University Hospital. They were divided into two equ...

Eligibility Criteria

Inclusion

  • \- Diabetes obesity

Exclusion

  • use of alcohol

Key Trial Info

Start Date :

December 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 20 2018

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04084925

Start Date

December 1 2017

End Date

December 20 2018

Last Update

September 12 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fayoum university hospital

Al Fayyum, Egypt, 63514

HOMA-IR as a Screening Test in NAFLD | DecenTrialz